Dr. Richard F Schlenk, MD
Claim this profileStudies Myelofibrosis
1 reported clinical trial
1 drug studied
More about Richard F Schlenk, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Richard F Schlenk, MD has experience with
- GB2064
Breakdown of trials Richard F Schlenk, MD has run
Myelofibrosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard F Schlenk, MD specialize in?
Richard F Schlenk, MD focuses on Myelofibrosis and other conditions. In particular, much of their work with Myelofibrosis has involved treating patients, or patients who are undergoing treatment.
Is Richard F Schlenk, MD currently recruiting for clinical trials?
No, Richard F Schlenk, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Richard F Schlenk, MD has studied deeply?
Yes, Richard F Schlenk, MD has studied treatments such as GB2064.
What is the best way to schedule an appointment with Richard F Schlenk, MD?
Apply for one of the trials that Richard F Schlenk, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.